Subscribe to Newsletter

September 2021 Issue of The Medicine Maker

In this issue, our cover features looks at the mRNA field – asking what lies ahead for mRNA post-pandemic, featuring contributions from CureVac, Sartorius, and more. We also speak with the Drugs for Neglected Diseases initiative to learn about a partnership that brought a new hep C treatment to Malaysia. In In My View, we cover advanced therapies, rapid-dissolve tablet technologies, and the pharma supply chain. We also sit down with Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Discovery & Development Drug Discovery

A Breath of Fresh Air

| Maryam Mahdi

Repurposing drugs could accelerate the development of a new cystic fibrosis drug.
Discovery & Development Drug Discovery

Archived Antivirals

| Angus Stewart

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.
Business & Regulation Standards & Regulation

Of Medicine and Machine Learning

| Angus Stewart, Stephanie Vine

AI is expanding into medicine. Are the world’s regulators ready?
Manufacture Contract Manufacturing Services

Lonza’s Cantonese Dream

| Angus Stewart

Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.
Discovery & Development Vaccines

Comirnaty for the Community?

| Stephanie Vine

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.
Business & Regulation Standards & Regulation

The Winding Road to the Frontline for Advanced Therapies

| Angi Robinson

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.
Manufacture Formulation

A Nice Cup of RDT

| Aditya Kumar

Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?
Manufacture Supply Chain

Moving Beyond Clinical Manufacturing

| Joe Garrity

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.
Manufacture Contract Manufacturing Services

Tackling the High-Potency Trend

| Sponsored by PCI

Defining the best strategies for working with highly potent drug substances.
Manufacture Advanced Medicine

mRNA: Reaching for the Sun

| Maryam Mahdi

What milestones will define the next era in the mRNA story?
Manufacture Bioprocessing - Upstream & Downstream

The Rise of mRNA: New Era, New Challenges

| Amélie Boulais, Jay Zhang, Nitin Chopra

Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.
Discovery & Development Clinical Trials

Malaysia in the Middle: Tackling Hep C in an Unfair World

| Angus Stewart

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.
Manufacture Drug Discovery

Bringing Certainty to CAR T-Cell Discovery

| Jim Ross

How can we maximize the potential and production of potentially life-saving therapies?
Manufacture Small Molecules

(Precious) Metal Will Never Die

| Sponsored by Sabin Metal

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.
Manufacture Trends & Forecasts

Crafting a Magic Bullet

| Stephanie Vine

How is the field of antibody drug conjugates being reshaped?

Manufacture Technology and Equipment

Now You See It

| Andrea Sardella

What are the challenges and best practices in quality control for difficult-to-inspect products?

Other issues of 2021